219 related articles for article (PubMed ID: 8964911)
1. Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins.
Gasque P; Thomas A; Fontaine M; Morgan BP
J Neuroimmunol; 1996 May; 66(1-2):29-40. PubMed ID: 8964911
[TBL] [Abstract][Full Text] [Related]
2. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
[TBL] [Abstract][Full Text] [Related]
3. Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59.
Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4195-202. PubMed ID: 11095615
[TBL] [Abstract][Full Text] [Related]
4. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
[TBL] [Abstract][Full Text] [Related]
5. Complement regulatory protein expression by a human oligodendrocyte cell line: cytokine regulation and comparison with astrocytes.
Gasque P; Morgan BP
Immunology; 1996 Nov; 89(3):338-47. PubMed ID: 8958045
[TBL] [Abstract][Full Text] [Related]
6. Cytokines affect resistance of human renal tumour cells to complement-mediated injury.
Blok VT; Gelderman KA; Tijsma OH; Daha MR; Gorter A
Scand J Immunol; 2003 Jun; 57(6):591-9. PubMed ID: 12791098
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis.
Singhrao SK; Neal JW; Rushmere NK; Morgan BP; Gasque P
Am J Pathol; 2000 Sep; 157(3):905-18. PubMed ID: 10980130
[TBL] [Abstract][Full Text] [Related]
8. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
Varsano S; Rashkovsky L; Shapiro H; Ophir D; Mark-Bentankur T
Clin Exp Immunol; 1998 Aug; 113(2):173-82. PubMed ID: 9717965
[TBL] [Abstract][Full Text] [Related]
9. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
[TBL] [Abstract][Full Text] [Related]
10. Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A.
Juhl H; Helmig F; Baltzer K; Kalthoff H; Henne-Bruns D; Kremer B
J Surg Oncol; 1997 Mar; 64(3):222-30. PubMed ID: 9121154
[TBL] [Abstract][Full Text] [Related]
11. Cell surface regulators of complement, 5I2 antigen, and CD59, in the rat eye and adnexal tissues.
Bardenstein DS; Cheyer C; Okada N; Morgan BP; Medof ME
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):519-24. PubMed ID: 9950613
[TBL] [Abstract][Full Text] [Related]
12. Expression of complement regulating factors in gastric cancer cells.
Inoue T; Yamakawa M; Takahashi T
Mol Pathol; 2002 Jun; 55(3):193-9. PubMed ID: 12032231
[TBL] [Abstract][Full Text] [Related]
13. Complement expression on astrocytes and astrocytoma cell lines: failure of complement regulation at the C3 level correlates with very low CD55 expression.
Spiller OB; Moretto G; Kim SU; Morgan BP; Devine DV
J Neuroimmunol; 1996 Dec; 71(1-2):97-106. PubMed ID: 8982108
[TBL] [Abstract][Full Text] [Related]
14. Complement regulatory proteins on the sperm surface: relevance to sperm motility.
Jiang H; Pillai S
Am J Reprod Immunol; 1998 Apr; 39(4):243-8. PubMed ID: 9553648
[TBL] [Abstract][Full Text] [Related]
15. [Complement regulatory proteins].
Miyagawa S
Nihon Rinsho; 2005 Apr; 63 Suppl 4():274-8. PubMed ID: 15861668
[No Abstract] [Full Text] [Related]
16. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.
Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3492-502. PubMed ID: 11006244
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.
Geis N; Zell S; Rutz R; Li W; Giese T; Mamidi S; Schultz S; Kirschfink M
Curr Cancer Drug Targets; 2010 Dec; 10(8):922-31. PubMed ID: 20879979
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta isoforms regulate the surface expression of membrane cofactor protein (CD46) and CD59 on human keratinocytes [corrected].
Pasch MC; Bos JD; Daha MR; Asghar SS
Eur J Immunol; 1999 Jan; 29(1):100-8. PubMed ID: 9933091
[TBL] [Abstract][Full Text] [Related]
19. Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases.
Miwa T; Song WC
Int Immunopharmacol; 2001 Mar; 1(3):445-59. PubMed ID: 11367529
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46).
Mead R; Hinchliffe SJ; Morgan BP
Immunology; 1999 Sep; 98(1):137-43. PubMed ID: 10469244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
